Table 1.
Patient Characteristics.
| Quartiles BED3 (Gy) | <145 | 145–180 | 180–225 | 225 | p-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (% | ||||||
| Total: | 76 | (22.1) | 112 | (32.6) | 46 | (13.4) | 110 | (32) | |||||
| Age (Median): | 79 | 77 | 73 | 77 | 0.62 | ||||||||
| Race: | 0.67 | ||||||||||||
| White | 66 | (86.8) | 96 | (85.7) | 41 | (89.1) | 97 | (88.2) | |||||
| Black | 8 | (10.5) | 15 | (13.4) | 1 | (2.2) | 9 | (8.2) | |||||
| Hispanic/Other | 2 | (2.6) | 1 | (0.9) | 1 | (2.2) | 3 | (2.7) | |||||
| Sex: | 0.06 | ||||||||||||
| Male | 40 | (52.6) | 79 | (70.5) | 32 | (69.6) | 75 | (68.2) | |||||
| Female | 36 | (47.4) | 33 | (29.5) | 14 | (30.4) | 35 | (31.8) | |||||
| Charlson-Deyo Score: | 0.34 | ||||||||||||
| 0 | 62 | (81.6) | 80 | (71.4) | 32 | (69.6) | 84 | (76.4) | |||||
| >0 | 14 | (18.4) | 32 | (28.6) | 14 | (30.4) | 26 | (23.6) | |||||
| Tumor Size (mm)(Median): | 42 | 37 | 35 | 35 | 0.08 | ||||||||
| Clinical T Stage: | <0.01 | ||||||||||||
| cT1a | 24 | (31.6) | 49 | (43.8) | 18 | (39.1) | 70 | (63.6) | |||||
| cT1b | 23 | (30.3) | 37 | (33) | 12 | (26.1) | 17 | (15.5) | |||||
| cT2 - cT4 | 14 | (18.4) | 9 | (8) | 9 | (19.6) | 10 | (9.1) | |||||
| Clinical N Stage: | <0.01 | ||||||||||||
| cN0 | 58 | (76.3) | 98 | (87.5) | 37 | (80.4) | 100 | (90.9) | |||||
| cN1 | 7 | (9.2) | 2 | (1.8) | 1 | (2.2) | 1 | (0.9) | |||||
| Clinical M Stage: | 0.33 | ||||||||||||
| cM0 | 63 | (82.9) | 93 | (83) | 41 | (89.1) | 94 | (85.5) | |||||
| cM1 | 8 | (10.5) | 8 | (7.1) | 1 | (2.2) | 6 | (5.5) | |||||
| Primary Site: | 0.64 | ||||||||||||
| Renal Parenchyma | 64 | (84.2) | 100 | (89.3) | 40 | (87) | 99 | (90) | |||||
| Renal Pelvis | 12 | (15.8) | 12 | (10.7) | 6 | (13) | 11 | (10) | |||||
| Laterality: | 0.55 | ||||||||||||
| Right | 43 | (56.6) | 55 | (49.1) | 27 | (58.7) | 63 | (57.3) | |||||
| Left | 33 | (43.4) | 57 | (50.9) | 19 | (41.3) | 47 | (42.7) | |||||
| Histology: | 0.06 | ||||||||||||
| Clear Cell Adenocarcinoma | 48 | (63.2) | 87 | (77.7) | 35 | (76.1) | 80 | (72.7) | |||||
| Papillary Renal Cell Carcinoma | 4 | (5.3) | 3 | (2.7) | 5 | (10.9) | 10 | (9.1) | |||||
| Transitional | 15 | (19.7) | 15 | (13.4) | 6 | (13) | 13 | (11.8) | |||||
| Other/Unspecified | 9 | (11.8) | 7 | (6.3) | 0 | (0) | 7 | (6.4) |